Projected Earnings Date: 2025-05-28    (Delayed quote data   2025-04-03)
Last
 109.68
Change
 ⇓ -6.32   (-5.45%)
Volume
  3,133,104
Open
 113.26
High
 113.70
Low
 109.57
8EMA (Daily)
 116.13
40EMA (Daily)
 125.87
50EMA (Daily)
 127.68
STO (Daily)
 16.720
MACD Hist (Daily)
 -1.025
8EMA (Weekly)
 123.597
40EMA (Weekly)
 133.85
50EMA (Weekly)
 134.18
STO (Weekly)
 8.920
MACD Hist (Weekly)
 -6.394
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2020 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (33%) and China (20%) representing the largest country concentrations.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com